Catheter Precision (VTAK) announced that its LockeT suture retention device will be highlighted during live procedural cases at the International Symposium of Left Atrial Appendage 2026 conference. The event, co-hosted by the Academy for Continued Healthcare Learning, ACHL, and ISLAA Foundation, will take place from March 5-6, 2026, at the Biltmore Hotel in Los Angeles, California. “We are proud that LockeT continues to gain traction at the industry’s most prestigious gatherings,” said David Jenkins, CEO of Catheter Precision. “Our recent feature at the Structural Heart Intervention and Imaging: A Practical Approach 2026 conference underscores the importance of live clinical cases. They offer an unmatched opportunity for physicians to validate the efficiency and cost-effectiveness of our suture retention solutions in a real-world setting.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision enters agreement to divest atherectomy catheter technologies
- Catheter Precision acquires 19.98% stake in Fly Flyte
- Catheter Precision Secures Strategic Financing and Converts Royalties
- Catheter Precision secures up to $36.5M in institutional financing
- Catheter Precision Restructures Financing and Strategic Investment Plans
